Clinical Report: At the Show - Day 3

Overview

The 2025 Global Specialty Lens Symposium showcased advancements in specialty contact lenses, particularly in myopia management and scleral lenses. Key discussions highlighted recent clinical evidence supporting the efficacy of various lens designs and their implications for patient care.

Background

The management of myopia is increasingly critical in clinical practice, with new evidence supporting proactive strategies. The 2025 Global Specialty Lens Symposium serves as a platform for sharing the latest research and clinical guidelines, particularly in specialty contact lenses. Understanding these advancements is essential for optimizing patient outcomes in myopia management and ocular surface disease.

Data Highlights

No numerical data was presented in this report.

Key Findings

• The International Myopia Institute's 2025 white papers emphasize evidence-based myopia management.
• Recent trials indicate that daily disposable defocus-incorporated soft lenses can slow myopia progression compared to single-vision lenses.
• Multifocal soft lenses have been shown to reduce refractive progression in children and adolescents.
• New literature on scleral lenses highlights their use in managing irregular corneas and ocular surface disease.
• Monitoring for adverse events associated with scleral lenses is crucial for patient safety.

Clinical Implications

Clinicians should integrate the latest evidence on specialty lenses into their practice to enhance myopia management strategies. Additionally, awareness of the indications and potential complications of scleral lenses is vital for effective patient monitoring and care.

Conclusion

The 2025 Global Specialty Lens Symposium underscores the importance of ongoing education and adaptation in specialty lens prescribing. Staying informed on recent advancements will aid in improving patient outcomes in myopia management and ocular surface health.

References

1. contact lens spectrum, At the Show - Day 2, 2025 -- At the Show - Day 2
2. contact lens spectrum, At the Show - Day 1, 2025 -- At the Show - Day 1
3. contact lens spectrum, At the Show, 2026 -- At the Show
4. IMI, 2025 Digest - PMC -- IMI—2025 Digest
5. Scleral lenses and PROSE: indications, complications, and future challenges, PubMed, 2025 -- Scleral lenses and PROSE: indications, complications, and future challenges
6. Eyecare Business — EB Premieres “Flaunt the Frame” Fashion Show Series at Vision Expo West
7. IMI—2025 Digest - PMC
8. Scleral lenses and PROSE: indications, complications, and future challenges - PubMed
9. FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia | FDA